Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gertrud Haas

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Peptides|March 29, 2011
PE-11, a peptide derived from chromogranin B, in the rat eyeKatrin Lorenz, Josef Troger, Oliver Gramlich, et al.
BMJ Open Ophthalmology|January 12, 2022
Proton beam radiation for iris melanoma: case series and review of literatureJasmine Alexandra Hauzinger, Georgios Blatsios, Gertrud Haas, et al.
Peptides|September 8, 2006
Neurokinin A and neurokinin B in the human retinaEduard Schmid, Johannes Leierer, Gerhard Kieselbach, et al.
Ocular Immunology and Inflammation|May 13, 2021
Uveitis in Tumor Patients Treated with Immunological Checkpoint- and Signal Transduction Pathway-InhibitorsStephan Thurau, Hendrik Engelke, Peter McCluskey, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Peptides|March 29, 2011
PE-11, a peptide derived from chromogranin B, in the rat eyeKatrin Lorenz, Josef Troger, Oliver Gramlich, et al.
BMJ Open Ophthalmology|January 12, 2022
Proton beam radiation for iris melanoma: case series and review of literatureJasmine Alexandra Hauzinger, Georgios Blatsios, Gertrud Haas, et al.
Peptides|September 8, 2006
Neurokinin A and neurokinin B in the human retinaEduard Schmid, Johannes Leierer, Gerhard Kieselbach, et al.
Ocular Immunology and Inflammation|May 13, 2021
Uveitis in Tumor Patients Treated with Immunological Checkpoint- and Signal Transduction Pathway-InhibitorsStephan Thurau, Hendrik Engelke, Peter McCluskey, et al.
Pageof 3